| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,244 | 13,332 | 11,040 | 14,469 | | Cost of Revenue | 3,883 | 3,858 | 3,094 | 4,677 | | | Gross Profit | 7,361 | 9,474 | 7,946 | 9,792 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,579 | 1,427 | 1,674 | 1,743 | | Non Recurring | 82 |
-
|
-
| 743 | | Others | 5,059 | 8,007 | 4,382 | 4,017 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 641 | 40 | 1,890 | 3,289 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 641 | 40 | 1,890 | 3,289 | | Interest Expense | 265 | 392 | 252 | 161 | | Income Before Tax | 376 | (352) | 1,638 | 3,128 | | Income Tax Expense | (40) | (110) | 631 | 789 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 416 | (242) | 1,007 | 2,339 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 416 | (242) | 1,007 | 2,339 | | Preferred Stock And Other Adjustments | (930) | (931) | (931) | (931) | | | Net Income Applicable To Common Shares | ($514) | ($1,173) | $76 | $1,408 |
|
0.09% Nasdaq 
0.0101 (0.22%) 
Income Statement
